c-src structure in human cancers with elevated pp60c-src activity

Br J Cancer. 1991 Sep;64(3):531-3. doi: 10.1038/bjc.1991.344.

Abstract

We used RNAase protection and restriction fragment length polymorphism assays to detect activating mutations of c-src in a spectrum of human tumours. No mutations were detected at codons 98, 381, 444, and 530. We conclude that mutational activation is not the mechanism of enhancement of pp60c-src-specific kinase activity found in a number of human cancer types.

MeSH terms

  • Base Sequence
  • Codon
  • Genes, src*
  • Humans
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Mutation*
  • Neoplasms / enzymology
  • Neoplasms / genetics*
  • Oligodeoxyribonucleotides
  • Polymorphism, Restriction Fragment Length
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins pp60(c-src) / genetics
  • Proto-Oncogene Proteins pp60(c-src) / metabolism*
  • RNA, Messenger / genetics

Substances

  • Codon
  • Oligodeoxyribonucleotides
  • RNA, Messenger
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins pp60(c-src)